Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000220995 | SCV000270963 | likely benign | not specified | 2015-10-04 | criteria provided, single submitter | clinical testing | p.Val51Ile in exon 2 of TSPEAR: This variant is not expected to have clinical si gnificance due to a lack of conservation across species, including mammals. Of n ote, 6 mammals have an isoleucine (Ile) at this position. In addition, computati onal prediction tools do not suggest a high likelihood of impact to the protein. Furthermore, this variant has been identified in 0.15% (97/65584) of European c hromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute .org; dbSNP rs150016894). |
Eurofins Ntd Llc |
RCV000730688 | SCV000858446 | uncertain significance | not provided | 2017-12-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000730688 | SCV001825586 | likely benign | not provided | 2020-11-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000730688 | SCV002426686 | likely benign | not provided | 2024-11-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003929900 | SCV004747044 | likely benign | TSPEAR-related disorder | 2024-01-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |